Image © Julie Wilkinson
Sounds like a dream come true, right? In the 80's we proved that an aspirin a day could decrease your risk of heart attack and stroke. Now, there is a chance that an aspirin-hybrid could combat cancer cells without the nasty side effects. It's still in the testing phase and it would be years before this was released to real humans - but cancer researchers at the Sophie Davis School of Biomedical Education in the City College of New York have just presented their "NOSH Aspirin" to the American Association for Cancer Research at the first annual meeting.
We already know that non-steroidal anti-inflammatory drugs (NSAIDs) can decrease inflammation, the risk of heart attack and stroke, and may help decrease your risk of developing colon cancer or a recurrence of the disease.
What we didn't know, was how to make aspirin and other NSAID's anti-carcinogen properties more potent, along with making them stomach-friendly for our older population. The American College of Gastroenterology tells us that most NSAIDs are notoriously rough on the stomach lining, potentially causing bleeding ulcers and gastrointestinal discomfort, and can amplify the effects of blood thinners.
Not the NOSH Aspirin, however. This hybrid creation is bound with gases - yes, I said gases - to not only make it a more potent cancer stopper, but also to decrease the side effects usually associated with NSAIDs. Hydrogen sulfide boosts the anti-carcinogen properties, while nitric oxide decreases the risk of harm to your stomach lining. In the trials, the NOSH Aspirin created an 85 percent reduction in human colon cancer cells in mice - apparently the cells started to "self-destruct", according to the study.
Before we get in line at our local pharmacy for this wonder-drug, remember this: it still has to complete toxicity testing and a whole slew of clinical trials before being released to the general public. I don't know about you - but an aspirin that could potentially help control colon, pancreatic, prostate, lung, breast cancers and leukemia... sign me up!